Back to RTW Investments, LP RTW Investments, LP

AXSMAXSM

Showing 7 of 29 quarters

Position history for RTW Investments, LPRTW Investments, LP's holdings in Axsome Therapeutics, Inc.

No. RTW Investments exited its AXSM (Axsome Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 888,001 shares worth $162.2M. RTW Investments already held AXSM in its Q1 2019 13F, the earliest on record, and held it in 28 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$376.5M

Total Shares Change

-4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$169.02
0
2025-Q4
Decreased
888,001
-20.6%
$162.2M1.6%$182.64
0
2025-Q3
Decreased
1.1M
-26.2%
$135.9M1.7%$121.45
0
2025-Q2
Decreased
1.5M
-48.1%
$158.3M2.3%$104.39
0
2025-Q1
Decreased
2.9M
-27.9%
$340.9M5.2%$116.63
0
2024-Q4
Decreased
4.1M
-3.3%
$342.8M5.2%$84.61
0
2024-Q3
Decreased
4.2M
-9.6%
$376.5M5.4%$89.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used